
The Washington Post @washingtonpost
Pfizer plans to apply for approval of its RSV vaccine by year's end, in hopes a vaccine could be available before next year's respiratory-illness season. https://t.co/XjwItW0T7b — PolitiTweet.org
Created
Tue Nov 01 13:26:57 +0000 2022
Likes
215
Retweets
58
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableThe Washington Post @washingtonpost
Pfizer plans to apply for approval of its RSV vaccine by year's end, in hopes a vaccine could be available before next year's respiratory-illness season. https://t.co/XjwItW0T7b — PolitiTweet.org